Daxor Corporation Announces New Data from Duke University and Highlights Key BVA Insights at American College of Cardiology’s 74th Annual Scientific Session and Expo
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 02 2025
0mins
Source: Globenewswire
Daxor Corporation's Presentation at ACC Conference: Daxor Corporation showcased its blood volume measurement technology at the American College of Cardiology conference, where new findings from Duke University highlighted blood volume analysis (BVA) as a more accurate method for assessing congestion in heart failure patients compared to traditional pressure measurements.
Research Findings on Volume Management: The Duke study revealed that common proxy markers like urine output and weight change do not correlate with true blood volume status, emphasizing the importance of BVA for effective heart failure treatment and improved patient outcomes.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
